511542-03-3

Basic information

• Product Name: (2R,3R)-2-bezyloxymethyl-3-[(E)-pentadec-1-enyl]oxirane
• Synonyms: (2R,3R)-2-bezyloxymethyl-3-[(E)-pentadec-1-enyl]oxirane
• CAS NO: 511542-03-3
• Molecular Weight: 372.591
• Mol File: 511542-03-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (2R,3R)-2-bezyloxymethyl-3-[(E)-pentadec-1-enyl]oxirane(CAS DataBase Reference)
• NIST Chemistry Reference: (2R,3R)-2-bezyloxymethyl-3-[(E)-pentadec-1-enyl]oxirane(511542-03-3)
• EPA Substance Registry System: (2R,3R)-2-bezyloxymethyl-3-[(E)-pentadec-1-enyl]oxirane(511542-03-3)

Safety Data

• Hazardous Substances Data: 511542-03-3(Hazardous Substances Data)

Upstream product

• 93255-83-5 (2E,4E)-octadeca-2,4-dien-1-ol 
• 100-39-0 benzyl bromide 
• 59451-68-2 ethyl (2E,4E)-octadeca-2,4-dienoate 
• 124-25-4 myristylaldehyde 
• 511542-09-9 (2E,3E)-octadeca-2,4-dienyloxymethylbenzene 

Downstream Products

• 511542-11-3 (4R,5S)-5-benzyloxymethyl-4-[(E)-pentadec-1-enyl]oxazolidin-2-one 
• 511542-12-4 1-((2R,3S)-2-benzyloxymethyl-3-[(E)-pentadec-1-enyl]aziridin-1-yl)ethanone 
• 511542-08-8 (2S,3S,4E)-2-amino-1-benzyloxyoctadec-4-en-3-ol 
• 511542-07-7 (2S,3R,4E)-2-amino-1-benzyloxyoctadec-4-en-3-ol 
• 511542-05-5 (2S,3R,4E)-3-amino-1-benzyloxyoctadec-4-en-2-ol 
• 511542-06-6 (2R,3S)-2-benzyloxymethyl-3-[(E)-pentadec-1-enyl]aziridine 
• 123-78-4 (2S,3R,4E)-2-amino-4-octadecene-1,3-diol 
• 511542-04-4 (2S,3S,4E)-3-amino-1-benzyloxyoctadec-4-en-2-ol 
• 511542-10-2 (4R,5S)-5-benzyloxymethyl-4-[(E)-pentadec-1-enyl]-3-(toluene-4-sulfonyl)oxazolidin-2-one 

Relevant articles and documents

Divergent synthesis of D-erythro-sphingosine, L-threo-sphingosine, and their regioisomers

Starting from a vinyl epoxide, a divergent synthesis of four sphingosine isomers is described. The remaining four isomers can easily be synthesized using the same methodology. Although numerous syntheses of sphingosine have been published, this is the first general route leading to all eight isomers in this important compound class. The synthetic strategy relies on regioselective opening of a vinyl epoxide and a vinylaziridine in the allylic position.